{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T11:05:51Z","timestamp":1784286351873,"version":"3.55.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100009367","name":"Mansoura University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009367","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Diabetic kidney disease (DKD) is a chronic microvascular complication of diabetes mellitus and a leading cause of chronic kidney disease worldwide. Microalbuminuria remains the current gold standard for the diagnosis and staging of DKD; however, it often reflects established renal injury rather than early pathological changes. Fatty acid\u2013binding protein 1 (FABP1), a cytoplasmic protein abundantly expressed in the renal proximal tubules, is released into the urine in response to tubular damage. FABP1 plays an essential role in intracellular fatty acid transport and metabolism and may serve as a potential biomarker for tubular involvement in pediatric diabetic kidney disease. A case\u2013control study was performed on 90 children (30 T1DM with DKD, 30 T1DM without DKD [non-DKD], and 30 controls). Albumin\u2013creatinine ratio (ACR) and serum FABP1 were ELISA measured. FABP1 was significantly higher in the DKD group versus non-DKD (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.026) and controls (\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.009). FABP1 positively correlated with ACR (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.25,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.018), total cholesterol (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.25,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.019), and LDL-C (\n                    <jats:italic>r<\/jats:italic>\n                    \u2009=\u20090.25,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009=\u20090.017). A cutoff\u2009&gt;\u2009189\u00a0ng\/L discriminated DKD from non-DKD (AUC\u2009=\u20090.67, sensitivity 63%, specificity 73%).\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:italic>Conclusion<\/jats:italic>\n                    : Serum FABP1 may represent a complementary biomarker of tubular involvement in pediatric diabetic kidney disease.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:table-wrap>\n                      <jats:table>\n                        <jats:tbody>\n                          <jats:tr>\n                            <jats:td colspan=\"3\">\n                              <jats:bold>What is Known:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Microalbuminuria detects DKD only after significant renal injury has occurred<\/jats:italic>\n                              .\u2022\n                              <jats:italic>FABP1 is released from proximal tubular cells in response to early tubular damage<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                          <jats:tr>\n                            <jats:td colspan=\"3\">\n                              <jats:bold>What is New:<\/jats:bold>\n                              \u2022\n                              <jats:italic>Serum FABP1 is associated with diabetic kidney disease in children with type 1 diabetes mellitus and correlates with albumin\u2013creatinine ratio<\/jats:italic>\n                              .\u2022\n                              <jats:italic>FABP1 may provide additional information on tubular involvement when used alongside conventional glomerular markers<\/jats:italic>\n                              .\n                            <\/jats:td>\n                          <\/jats:tr>\n                        <\/jats:tbody>\n                      <\/jats:table>\n                    <\/jats:table-wrap>\n                  <\/jats:p>","DOI":"10.1007\/s00431-026-07142-8","type":"journal-article","created":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T01:43:27Z","timestamp":1781574207000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of FABP1 as a biomarker of diabetic kidney disease in children with type 1 diabetes"],"prefix":"10.1007","volume":"185","author":[{"given":"Hadil Mohamed","family":"Aboelenin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heba","family":"ElTaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rasha","family":"Elzehery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Mahmoud","family":"Nosir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Al-Haggar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,16]]},"reference":[{"key":"7142_CR1","doi-asserted-by":"publisher","unstructured":"Katsarou A, Gudbj\u00f6rnsdottir S, Rawshani A, Dabelea D, Bonifacio E, Anderson BJ, Jacobsen LM, Schatz DA, Lernmark \u00c5 (2017) Type 1 diabetes mellitus. Nature reviews disease primers 3:17016. https:\/\/doi.org\/10.1038\/nrdp.2017.16","DOI":"10.1038\/nrdp.2017.16"},{"key":"7142_CR2","doi-asserted-by":"publisher","unstructured":"Shalaby NM, Shalaby NM\u00a0(2015) Study of ambulatory blood pressure in diabetic children: prediction of early renal insult. Therapeutics and clinical risk management 11:1531\u20131537. Published October 5, 2015. https:\/\/doi.org\/10.2147\/TCRM.S87751","DOI":"10.2147\/TCRM.S87751"},{"issue":"8","key":"7142_CR3","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.1111\/pedi.13444","volume":"23","author":"P Bjornstad","year":"2022","unstructured":"Bjornstad P, Dart A, Donaghue KC, Dost A, Feldman EL, Tan GS et al (2022) <scp>ISPAD<\/scp> Clinical practice consensus guidelines 2022: microvascular and macrovascular complications in children and adolescents with diabetes. Pediatr Diabetes 23(8):1432\u20131450","journal-title":"Pediatr Diabetes"},{"issue":"4","key":"7142_CR4","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","volume":"105","author":"A Levin","year":"2024","unstructured":"Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK et al (2024) Executive summary of the KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease: known knowns and known unknowns. Kidney Int 105(4):684\u2013701","journal-title":"Kidney Int"},{"issue":"5","key":"7142_CR5","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1111\/pedi.13019","volume":"21","author":"NAB Salem","year":"2020","unstructured":"Salem NAB, El Helaly RM, Ali IM, Ebrahim HAA, Alayooti MM, El Domiaty HA et al (2020) Urinary cyclophilin A and serum cystatin C as biomarkers for diabetic nephropathy in children with type 1 diabetes. Pediatr Diabetes 21(5):846\u2013855","journal-title":"Pediatr Diabetes"},{"issue":"8","key":"7142_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.4239\/wjd.v13.i8.587","volume":"13","author":"C Muntean","year":"2022","unstructured":"Muntean C, Starcea IM, Banescu C (2022) Diabetic kidney disease in pediatric patients: a current review. World J Diabetes 13(8):587\u2013599","journal-title":"World J Diabetes"},{"issue":"7","key":"7142_CR7","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1007\/s00592-020-01656-9","volume":"58","author":"F Barutta","year":"2021","unstructured":"Barutta F, Bellini S, Canepa S, Durazzo M, Gruden GJAd. (2021) Novel biomarkers of diabetic kidney disease: current status and potential clinical application. Acta Diabetol 58(7):819\u2013830","journal-title":"Acta Diabetol"},{"issue":"11-12","key":"7142_CR8","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1159\/000521447","volume":"94","author":"A Da\u011fdeviren \u00c7ak\u0131r","year":"2021","unstructured":"Da\u011fdeviren \u00c7ak\u0131r A, Sayg\u0131l\u0131 SK, Canpolat N, Konuko\u011flu D, Turan H, \u00c7al\u0131\u015fkan S et al (2021) Elevated urinary VEGF-A, transferrin, and angiotensinogen levels in normoalbuminuric children and adolescents with type 1 diabetes: can they be early markers of diabetic kidney disease? Horm Res Paediatr 94(11\u201312):426\u2013432","journal-title":"Horm Res Paediatr"},{"issue":"4","key":"7142_CR9","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1007\/s00467-015-3253-9","volume":"31","author":"J-S Suh","year":"2016","unstructured":"Suh J-S, Kim S-H, Cho KS, Jung I-A, Cho WK, Jeon YJ et al (2016) Urinary markers in the early stage of nephropathy in patients with childhood-onset type 1 diabetes. Pediatr Nephrol 31(4):623\u2013631","journal-title":"Pediatr Nephrol"},{"issue":"15","key":"7142_CR10","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.7150\/ijms.49078","volume":"17","author":"IT Tsai","year":"2020","unstructured":"Tsai IT, Wu C-C, Hung W-C, Lee T-L, Hsuan C-F, Wei C-T et al (2020) FABP1 and FABP2 as markers of diabetic nephropathy. Int J Med Sci 17(15):2338\u20132345","journal-title":"Int J Med Sci"},{"issue":"12","key":"7142_CR11","doi-asserted-by":"publisher","first-page":"2238","DOI":"10.1194\/jlr.R056705","volume":"56","author":"G Wang","year":"2015","unstructured":"Wang G, Bonkovsky HL, de Lemos A, Burczynski FJ (2015) Recent insights into the biological functions of liver fatty acid binding protein 1. J Lipid Res 56(12):2238\u20132247","journal-title":"J Lipid Res"},{"issue":"1","key":"7142_CR12","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00540-015-2095-8","volume":"30","author":"Y Obata","year":"2015","unstructured":"Obata Y, Kamijo-Ikemori A, Ichikawa D, Sugaya T, Kimura K, Shibagaki Y et al (2015) Clinical usefulness of urinary liver-type fatty-acid-binding protein as a perioperative marker of acute kidney injury in patients undergoing endovascular or open-abdominal aortic aneurysm repair. J Anesth 30(1):89\u201399","journal-title":"J Anesth"},{"issue":"2","key":"7142_CR13","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/SLA.0b013e318207a767","volume":"253","author":"G Thuijls","year":"2011","unstructured":"Thuijls G, Wijck K, Grootjans J, Derikx JPM, van Bijnen AA, Heineman E et al (2011) Early diagnosis of intestinal ischemia using urinary and plasma fatty acid binding proteins. Ann Surg 253(2):303\u2013308","journal-title":"Ann Surg"},{"key":"7142_CR14","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.cca.2015.03.017","volume":"445","author":"Y Xu","year":"2015","unstructured":"Xu Y, Xie Y, Shao X, Ni Z, Mou S (2015) L-FABP: a novel biomarker of kidney disease. Clin Chim Acta 445:85\u201390","journal-title":"Clin Chim Acta"},{"issue":"3","key":"7142_CR15","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1038\/ki.2014.301","volume":"87","author":"SK Parr","year":"2015","unstructured":"Parr SK, Clark AJ, Bian A, Shintani AK, Wickersham NE, Ware LB et al (2015) Urinary L-FABP predicts poor outcomes in critically ill patients with early acute kidney injury. Kidney Int 87(3):640\u2013648","journal-title":"Kidney Int"},{"issue":"4","key":"7142_CR16","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/sj.ki.5002721","volume":"73","author":"D Portilla","year":"2008","unstructured":"Portilla D, Dent C, Sugaya T, Nagothu KK, Kundi I, Moore P et al (2008) Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int 73(4):465\u2013472","journal-title":"Kidney Int"},{"issue":"1","key":"7142_CR17","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.21608\/ejhm.2022.266047","volume":"89","author":"MMM Hassaan","year":"2022","unstructured":"Hassaan MMM, Elsayed AME, Deraz HA, Hussein AG (2022) Fatty acid binding protein (1 & 2) as markers of diabetic nephropathy in elderly patients with type 2 diabetes mellitus. Egyptian J Hosp Med 89(1):5778\u20135783","journal-title":"Egyptian J Hosp Med"},{"issue":"4","key":"7142_CR18","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1080\/10245330500155598","volume":"10","author":"MA El-Ziny","year":"2005","unstructured":"El-Ziny MA, Al-Tonbary YA, Salama OS, Bakr AA, Al-Marsafawy H, Elsharkawy AA (2005) Low turnover bone disease in Egyptian children with acute leukemia. Hematology 10(4):327\u2013333","journal-title":"Hematology"},{"issue":"11","key":"7142_CR19","doi-asserted-by":"publisher","first-page":"1832","DOI":"10.2215\/CJN.01640309","volume":"4","author":"GJ Schwartz","year":"2009","unstructured":"Schwartz GJ, Work DF (2009) Measurement and estimation of GFR in children and adolescents. Clin J Am Soc Nephrol 4(11):1832\u20131843","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"7142_CR20","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1681\/ASN.2010020194","volume":"22","author":"C Forsblom","year":"2011","unstructured":"Forsblom C, Harjutsalo V, Thorn LM, Wad\u00e9n J, Tolonen N, Saraheimo M et al (2011) Competing-risk analysis of ESRD and death among patients with type 1 diabetes and macroalbuminuria. J Am Soc Nephrol 22(3):537\u2013544","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"7142_CR21","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2337\/dc10-1392","volume":"34","author":"A Kamijo-Ikemori","year":"2011","unstructured":"Kamijo-Ikemori A, Sugaya T, Yasuda T, Kawata T, Ota A, Tatsunami S et al (2011) Clinical significance of urinary liver-type fatty acid\u2013binding protein in diabetic nephropathy of type 2 diabetic patients. Diabetes Care 34(3):691\u2013696","journal-title":"Diabetes Care"},{"issue":"3","key":"7142_CR22","doi-asserted-by":"publisher","first-page":"108414","DOI":"10.1016\/j.jdiacomp.2023.108414","volume":"37","author":"M Abo El-Asrar","year":"2023","unstructured":"Abo El-Asrar M, Ismail EAR, Elnhrawy AM, Thabet RA (2023) Fatty acid binding protein 1 (FABP1) and fatty acid binding protein 2 (FABP2) as a link between diabetic nephropathy and subclinical atherosclerosis in children and adolescents with type 1 diabetes. J Diabetes Complications 37(3):108414","journal-title":"J Diabetes Complications"},{"key":"7142_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/cells11203236","author":"JR Schelling","year":"2022","unstructured":"Schelling JR (2022) The contribution of lipotoxicity to diabetic kidney disease. Cells. https:\/\/doi.org\/10.3390\/cells11203236","journal-title":"Cells"},{"issue":"1","key":"7142_CR24","doi-asserted-by":"publisher","first-page":"5778","DOI":"10.21608\/ejhm.2022.266047","volume":"89","author":"MMM Hassaan","year":"2022","unstructured":"Hassaan MMM, Elsayed AME, Deraz HA, Hussein AG (2022) Fatty acid binding protein (1 & 2) as markers of diabetic nephropathy in elderly patients with type 2 diabetes mellitus %. Egypt J Hospi Med 89(1):5778\u201383","journal-title":"Egypt J Hospi Med"},{"issue":"8","key":"7142_CR25","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.2337\/diacare.28.8.2038","volume":"28","author":"K Suzuki","year":"2005","unstructured":"Suzuki K, Babazono T, Murata H, Iwamoto Y (2005) Clinical significance of urinary liver-type fatty acid\u2013binding protein in patients with diabetic nephropathy. Diabetes Care 28(8):2038\u20132039","journal-title":"Diabetes Care"},{"issue":"7","key":"7142_CR26","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.2337\/dc12-1868","volume":"36","author":"NM Panduru","year":"2013","unstructured":"Panduru NM, Forsblom C, Saraheimo M, Thorn L, Bierhaus A, Humpert PM et al (2013) Urinary liver-type fatty acid\u2013binding protein and progression of diabetic nephropathy in type 1 diabetes. Diabetes Care 36(7):2077\u20132083","journal-title":"Diabetes Care"},{"issue":"2","key":"7142_CR27","doi-asserted-by":"publisher","first-page":"128","DOI":"10.4093\/dmj.2017.41.2.128","volume":"41","author":"S Palazhy","year":"2017","unstructured":"Palazhy S, Viswanathan V (2017) Lipid abnormalities in type 2 diabetes mellitus patients with overt nephropathy. Diabetes Metab J 41(2):128","journal-title":"Diabetes Metab J"},{"issue":"7","key":"7142_CR28","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3346\/jkms.2012.27.7.784","volume":"27","author":"H-W Chae","year":"2012","unstructured":"Chae H-W, Shin J-I, Kwon A-R, Kim H-S, Kim D-H (2012) Spot urine albumin to creatinine ratio and serum cystatin C are effective for detection of diabetic nephropathy in childhood diabetic patients. J Korean Med Sci 27(7):784","journal-title":"J Korean Med Sci"},{"issue":"10","key":"7142_CR29","doi-asserted-by":"publisher","first-page":"3113","DOI":"10.2337\/dc13-0190","volume":"36","author":"CR Elley","year":"2013","unstructured":"Elley CR, Robinson T, Moyes SA, Kenealy T, Collins J, Robinson E et al (2013) Derivation and validation of a renal risk score for people with type 2 diabetes. Diabetes Care 36(10):3113\u20133120","journal-title":"Diabetes Care"},{"issue":"8","key":"7142_CR30","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1681\/ASN.V1081778","volume":"10","author":"JA Miller","year":"1999","unstructured":"Miller JA (1999) Impact of hyperglycemia on the Renin Angiotensin System in early human type 1 diabetes mellitus. J Am Soc Nephrol 10(8):1778\u20131785","journal-title":"J Am Soc Nephrol"},{"issue":"14","key":"7142_CR31","doi-asserted-by":"publisher","DOI":"10.1001\/jama.294.14.1782","volume":"294","author":"P Finne","year":"2005","unstructured":"Finne P (2005) Incidence of end-stage renal disease in patients with type 1 diabetes. JAMA 294(14):1782","journal-title":"JAMA"},{"issue":"1","key":"7142_CR32","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.mcna.2012.10.010","volume":"97","author":"C Maric-Bilkan","year":"2013","unstructured":"Maric-Bilkan C (2013) Obesity and diabetic kidney disease. Med Clin North Am 97(1):59\u201374","journal-title":"Med Clin North Am"},{"issue":"4","key":"7142_CR33","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1136\/adc.2004.056424","volume":"90","author":"O Kordonouri","year":"2005","unstructured":"Kordonouri O (2005) Natural course of autoimmune thyroiditis in type 1 diabetes: association with gender, age, diabetes duration, and puberty. Arch Dis Child 90(4):411\u2013414","journal-title":"Arch Dis Child"},{"issue":"1","key":"7142_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2337\/dc16-0430","volume":"40","author":"ML Katz","year":"2016","unstructured":"Katz ML, Kollman CR, Dougher CE, Mubasher M, Laffel LMB (2016) Influence of HbA1c and BMI on lipid trajectories in youths and young adults with type 1 diabetes. Diabetes Care 40(1):30\u201337","journal-title":"Diabetes Care"}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07142-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07142-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T10:24:50Z","timestamp":1784283890000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07142-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,16]]},"references-count":34,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["7142"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07142-8","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,16]]},"assertion":[{"value":"30 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted by the principles outlined in the Declaration of Helsinki. The study protocol was approved by the Research Ethics Committee of Faculty of Medicine, Mansoura University (Code No. MS\/22.02.1859) and followed by the Institutional Research Board. Informed consents were obtained from all parents of the children included in this study.","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent was obtained from all patient caregivers before inclusion in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"504"}}